Your search returned 80 studies. (Get alerts for new studies):
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
23 Locations available
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Fallopian Tube Neoplasms - Ovarian Cancer - Primary Peritoneal
1 Location available
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Conditions: Endometrial Cancer - Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Gastrointestinal Carcinoma - Pancreatic Carcinoma - Lung Cancer - Esophageal Carcinoma
1 Location available
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Conditions: Ovarian Cancer
1 Location available
- Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in GYN Patients
Conditions: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1 Location available
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer - Stage IIA Fallopian Tube Cancer - Stage IIA Ovarian Epithelial Cancer - Stage IIA Primary Peritoneal Cavity Cancer - Stage IIB Fallopian T
1 Location available
- VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal C
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
51 Locations available
- Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Fea
Conditions: Ovarian Cancer
1 Location available
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Pr
Conditions: Fallopian Tube Cancer - Metastatic Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
3 Locations available
- Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and P
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer,
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
3 Locations available
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
95 Locations available
- Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Breast Cancer - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor - Recurrent Primary Peritoneal Cavity Cancer - Stage IIA Ovarian Epithelial Cancer - Stage IIA Ovarian Germ Cell Tumor - St
1 Location available
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
18 Locations available
- Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epi
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Weight Changes
132 Locations available
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
101 Locations available
- First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- TRINOVA-2: Trebananib in Ovarian Cancer-2
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
8 Locations available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- Accelerating Gastrointestinal Recovery
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breas
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Peritoneal Cancer - Breast Carcinoma
2 Locations available
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - Breast Cancer
1 Location available
- Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or P
Conditions: Fallopian Tube Cancer - Peritoneal Cavity Cancer - Recurrent Ovarian Epithelial Cancer
1 Location available
- CRLX101 for Recurrent Ovarian/Tubal/Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
4 Locations available
- Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
21 Locations available
- 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Conditions: Ovarian Neoplasms - Ovarian Cancer - Fallopian Tube Neoplasms - Fallopian Tube Cancer
1 Location available
- Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Comb
Conditions: Ovarian Cancer - Fallopian Tubes Cancer - Peritoneal Cancer
6 Locations available
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
32 Locations available
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
7 Locations available
- Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
30 Locations available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurren
8 Locations available
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
22 Locations available
- Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
3 Locations available
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cis
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
4 Locations available
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers
Conditions: Mixed Muellerian Cancer - Cervical Cancer - Ovarian Cancer - Breast Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer - Endometrial Cancer - Carcinosarcoma
1 Location available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Uterine Cancer - Vaginal Cancer - Vulvar Cancer
1 Location available
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
209 Locations available
- Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal C
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
10 Locations available
- Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remis
Conditions: Fallopian Tubes - Ovarian Cancer - Peritoneal Cancer
1 Location available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
181 Locations available
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
3 Locations available
- Beta-Blocker / Ovarian
Conditions: Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer - Stage IV Ovarian Cancer - Recurrent Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Conditions: Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Pseudomyxoma Peritonei - Recurrent Cervical Cancer - Recurrent Endometrial Carcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor
1 Location available
- A Study of LY2228820 for Recurrent Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
15 Locations available
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
118 Locations available
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
164 Locations available
- Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Anxiety Disorder - Fallopian Tube Cancer - Fatigue - Nausea and Vomiting - Neurotoxicity - Ovarian Cancer - Primary Peritoneal Cavity Cancer
111 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
- Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Peritoneal Neoplasms - Fallopian Tube Neoplasms
1 Location available
- Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer - Stage IV Fallopian Tube Cancer - Stage IV Ovarian Epithelial Cancer - Stage IV Primary Peritoneal Cavity Cancer
2 Locations available
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer - Endometrial Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Sarcoma - Uterine Leiomyomata - Vaginal Cancer - Vulvar Cancer
1 Location available
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
248 Locations available
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
255 Locations available
- Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
27 Locations available
- Veliparib, Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or F
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial
12 Locations available
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
131 Locations available
- Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
1 Location available
- A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
3 Locations available
- A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remis
Conditions: Biochemical-recurrent Only Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
11 Locations available
- Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
1 Location available
|